Abstract
Human genetic peroxisomal biogenesis disorders (PBDs), such as Zellweger syndrome, comprise 13 different complementation groups (CGs). Eleven peroxin genes, termed PEXs, responsible for PBDs have been identified, whereas pathogenic genes for PBDs of 2 CGs, CG-A (the same CG as CG8 in the United States and Europe) and CG6, remained unidentified. We herein provide several lines of novel evidence indicating that PEX6, the pathogenic gene for CG4, is impaired in PBD of CG6. Expression of PEX6 restored peroxisome assembly in fibroblasts from a CG6 PBD patient. This patient was a compound heterozygote for PEX6 gene alleles. Accordingly, by merging CG6 with CG4, human PBDs are now classified into 12 CGs.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: December 25, 2000 / Accepted: February 5, 2001
Rights and permissions
About this article
Cite this article
Matsumoto, N., Tamura, S., Moser, A. et al. The peroxin Pex6p gene is impaired in peroxisomal biogenesis disorders of complementation group 6. J Hum Genet 46, 273–277 (2001). https://doi.org/10.1007/s100380170078
Issue Date:
DOI: https://doi.org/10.1007/s100380170078
This article is cited by
-
A novel mutation in the PEX12 gene causing a peroxisomal biogenesis disorder
Molecular Biology Reports (2015)
-
A founder mutation in the PEX6 gene is responsible for increased incidence of Zellweger syndrome in a French Canadian population
BMC Medical Genetics (2012)
-
The pathogenic peroxin Pex26p recruits the Pex1p–Pex6p AAA ATPase complexes to peroxisomes
Nature Cell Biology (2003)